C8 Health's Galia Rosen-Schwarz Honored as Stevie® Award Finalist for Most Innovative Woman in Healthcare
C8 Health's Galia Rosen-Schwarz Honored as Finalist for 2025 Stevie® Award
C8 Health, pioneering the implementation of best practices for clinical teams, proudly announces that its Co-founder and CEO, Galia Rosen-Schwarz, has been recognized as a finalist in the prestigious 22nd annual Stevie® Awards for Women in Business. This honor places her in the running for the title of Most Innovative Woman of the Year in the Healthcare sector, acknowledging her influential work and leadership within the organization.
Rosen-Schwarz’s recognition as a finalist comes as no surprise, given the remarkable accomplishments that C8 Health has achieved under her guidance. The healthcare platform has significantly impacted over 100 hospitals across the United States, including many of the nation’s top academic centers such as Mount Sinai, UCSF Health, and Brigham Women's. Such collaborations exemplify the effectiveness of C8 Health's implementation strategies that empower healthcare practitioners to enhance their clinical practices.
A testament to the efficacy of C8 Health's offerings is its exclusive partnerships with notable healthcare societies including the American Society of Anesthesiologists (ASA) and the Society for Obstetric Anesthesia and Perinatology (SOAP). These collaborations ensure that vetted guidelines are accessible to over 2,000 anesthesiologists, allowing for informed and evidence-based clinical decisions in their practices.
User engagement is also a forte for C8 Health. With over 90% adoption reported within six months of deployment, the platform demonstrates a strong traction and engagement from clinical staff. The successful launch of Panda AI has further delivered efficiency, with 88% of clinicians noting significant time savings and over 50% sustaining active weekly usage of the platform.
Rosen-Schwarz emphasizes the transformative nature of C8 Health, stating, "This recognition validates not just my journey, but the incredible work our entire team does every day to bridge the gap between evidence and practice in healthcare. When we make it easy for clinicians to access best practices at the point of care, we're not just solving a technology problem—we're reducing burnout, improving quality, and ultimately saving lives."
The Stevie Awards are dedicated to honoring the achievements of women executives, entrepreneurs, and employees from organizations worldwide. This year, more than 1,500 entries were submitted from organizations and individuals across 48 nations, showcasing the dynamic contributions of women in various industries. The final selections will be determined by the scores of over 190 global business professionals on seven judging committees, and winners will be announced at a gala event in New York City on November 10th. Over 400 women and guests are expected to partake in this celebratory gathering, which will also feature live broadcasts.
For those looking to witness this monumental award ceremony and recognize the contributions of women leaders like Rosen-Schwarz in reshaping the healthcare landscape, there is an anticipation of an inspiring evening filled with acknowledgement and inspiration. The commitment to elevating healthcare standards and practices through innovative technology continues to be a focal point at C8 Health, and Rosen-Schwarz’s leadership is a beacon of progress in the industry.
The imminent event not only celebrates the nominees but also serves to inspire upcoming generations of female leaders in healthcare and beyond. Galia Rosen-Schwarz's journey and the growth of C8 Health exemplify how innovative thinking and collaborative efforts can lead to substantial advancements in patient care and clinician support.
C8 Health continues to pave the way for technological integration in healthcare practices, fostering an environment where clinical teams can thrive and provide superior patient outcomes. As the healthcare industry evolves, the contributions and innovations led by visionaries like Rosen-Schwarz will undoubtedly continue to make a profound impact, reshaping the future of medical practices around the world.